Interrogating the Role of Receptor-Mediated Mechanisms: Biological Fate of Peptide-Functionalized Radiolabeled Gold Nanoparticles in Tumor Mice

Bioconjugate Chemistry

Volumn 27, Issue 4, 2016, Pages 1153-1164

  Silva, Francisco ^a   Zambre, Ajit ^b   Campello, Maria Paula Cabral ^a   Gano, Lurdes ^a   Santos, Isabel ^a   Ferraria, Ana Maria ^a   Ferreira, Maria João ^a   Singh, Amolak ^b   Upendran, Anandhi ^c   Paulo, António ^a   Kannan, Raghuraman ^b,c  

^a INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^b University of Missouri   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BAYESIAN NETWORKS; FIBER OPTIC SENSORS; GOLD COMPOUNDS; GOLD NANOPARTICLES; MAMMALS; METAL NANOPARTICLES; TUMORS;

BIOLOGICAL STUDIES; FUNCTIONALIZED; FUNCTIONALIZED GOLD NANOPARTICLES; GOLD NANOPARTICLE; GOLD NANOPARTICLES; HUMAN PROSTATE; IN-VIVO; INTRAPERITONEAL ADMINISTRATION; INTRAVENOUS ADMINISTRATION; TRANSPORT MECHANISM;

PEPTIDES;

BOMBESIN; CYSTEINE; GALLIUM 67; GASTRIN RELEASING PEPTIDE RECEPTOR; GOLD NANOPARTICLE; NANOCONJUGATE; PENTETIC ACID DERIVATIVE; TETRAXETAN; THIOL DERIVATIVE; GOLD; METAL NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONJUGATE; DRUG DISTRIBUTION; DRUG UPTAKE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; PROSTATE CANCER; RADIOACTIVITY; RECEPTOR AFFINITY; ANIMAL; CHEMISTRY; EXPERIMENTAL NEOPLASM; METABOLISM; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; GOLD; HUMANS; MALE; METAL NANOPARTICLES; MICE; NEOPLASMS, EXPERIMENTAL;

EID: 84965104329     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/acs.bioconjchem.6b00102     Document Type: Article

References (63)

1. Chanda, N., Kattumuri, V., Shukla, R., Zambre, A., Katti, K., Upendran, A., Kulkarni, R. R., Kan, P., Fent, G. M., and Casteel, S. W. et al. 2010, Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity Proc. Natl. Acad. Sci. U. S. A. 107, 8760-5 10.1073/pnas.1002143107
2. Chanda, N., Shukla, R., Katti, K. V., and Kannan, R. (2009) Gastrin releasing protein receptor specific gold nanorods: breast and prostate tumor avid nanovectors for molecular imaging Nano Lett. 9, 1798-805 10.1021/nl8037147
3. Brannon-Peppas, L. and Blanchette, J. O. (2004) Nanoparticle and targeted systems for cancer therapy Adv. Drug Delivery Rev. 56, 1649-59 10.1016/j.addr.2004.02.014
4. Dreaden, E. C., Mackey, M. A., Huang, X. H., Kang, B., and El-Sayed, M. A. (2011) Beating cancer in multiple ways using nanogold Chem. Soc. Rev. 40, 3391-3404 10.1039/c0cs00180e
5. Peer, D., Karp, J. M., Hong, S., FarokHzad, O. C., Margalit, R., and Langer, R. (2007) Nanocarriers as an emerging platform for cancer therapy Nat. Nanotechnol. 2, 751-760 10.1038/nnano.2007.387
6. Master, A. M. and Sen Gupta, A. (2012) EGF receptor-targeted nanocarriers for enhanced cancer treatment Nanomedicine (London, U. K.) 7, 1895-906 10.2217/nnm.12.160
7. Kudgus, R. A., Walden, C. A., McGovern, R. M., Reid, J. M., Robertson, J. D., and Mukherjee, P. (2014) Tuning pharmacokinetics and biodistribution of a targeted drug delivery system through incorporation of a passive targeting component Sci. Rep. 4, 5669 10.1038/srep05669
8. Bhattacharyya, S., Bhattacharya, R., Curley, S., McNiven, M. A., and Mukherjee, P. (2010) Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis Proc. Natl. Acad. Sci. U. S. A. 107, 14541-6 10.1073/pnas.1006507107
9. Huang, X., Peng, X., Wang, Y., Wang, Y., Shin, D. M., El-Sayed, M. A., and Nie, S. (2010) A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands ACS Nano 4, 5887-96 10.1021/nn102055s
10. Dreaden, E. C., Austin, L. A., Mackey, M. A., and El-Sayed, M. A. (2012) Size matters: gold nanoparticles in targeted cancer drug delivery Ther. Delivery 3, 457-78 10.4155/tde.12.21
11. Hirn, S., Semmler-Behnke, M., Schleh, C., Wenk, A., Lipka, J., Schaffler, M., Takenaka, S., Möller, W., Schmid, G., and Simon, U. et al. 2011, Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration Eur. J. Pharm. Biopharm. 77, 407-16 10.1016/j.ejpb.2010.12.029
12. Verma, A. and Stellacci, F. (2010) Effect of Surface Properties on Nanoparticle-Cell Interactions Small 6, 12-21 10.1002/smll.200901158
13. Arvizo, R. R., Miranda, O. R., Moyano, D. F., Walden, C. A., Giri, K., Bhattacharya, R., Robertson, J. D., Rotello, V. M., Reid, J. M., and Mukherjee, P. (2011) Modulating pharmacokinetics, tumor uptake and biodistribution by engineered nanoparticles PLoS One 6, e24374 10.1371/journal.pone.0024374
14. Arvizo, R. R., Miranda, O. R., Thompson, M. A., Pabelick, C. M., Bhattacharya, R., Robertson, J. D., Rotello, V. M., Prakash, Y. S., and Mukherjee, P. (2010) Effect of nanoparticle surface charge at the plasma membrane and beyond Nano Lett. 10, 2543-8 10.1021/nl101140t
15. Khan, J. A., Kudgus, R. A., Szabolcs, A., Dutta, S., Wang, E., Cao, S., Curran, G. L., Shah, V., Curley, S., and Mukhopadhyay, D. et al. 2011, Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo PLoS One 6, e20347 10.1371/journal.pone.0020347
16. Aggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A., and McNeil, S. E. (2009) Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy Adv. Drug Delivery Rev. 61, 428-37 10.1016/j.addr.2009.03.009
17. Wolfram, J., Yang, Y., Shen, J., Moten, A., Chen, C., Shen, H., Ferrari, M., and Zhao, Y. (2014) The nano-plasma interface: Implications of the protein corona Colloids Surf., B 124, 17-24 10.1016/j.colsurfb.2014.02.035
18. Wang, Y., Liu, Y., Luehmann, H., Xia, X., Brown, P., Jarreau, C., Welch, M., and Xia, Y. (2012) Evaluating the pharmacokinetics and in vivo cancer targeting capability of Au nanocages by positron emission tomography imaging ACS Nano 6, 5880-8 10.1021/nn300464r
19. Perrault, S. D., Walkey, C., Jennings, T., Fischer, H. C., and Chan, W. C. (2009) Mediating tumor targeting efficiency of nanoparticles through design Nano Lett. 9, 1909-15 10.1021/nl900031y
20. Perrault, S. D. and Chan, W. C. (2010) In vivo assembly of nanoparticle components to improve targeted cancer imaging Proc. Natl. Acad. Sci. U. S. A. 107, 11194-9 10.1073/pnas.1001367107
21. Kodiha, M., Wang, Y. M., Hutter, E., Maysinger, D., and Stochaj, U. (2015) Off to the organelles-killing cancer cells with targeted gold nanoparticles Theranostics 5, 357-70 10.7150/thno.10657
22. Zhou, J. and Rossi, J. J. (2014) Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy Mol. Ther. - Nucleic Acids 3, e169 10.1038/mtna.2014.21
23. Ding, Y., Jiang, Z., Saha, K., Kim, C. S., Kim, S. T., Landis, R. F., and Rotello, V. M. (2014) Gold nanoparticles for nucleic acid delivery Mol. Ther. 22, 1075-83 10.1038/mt.2014.30
24. Rana, S., Bajaj, A., Mout, R., and Rotello, V. M. (2012) Monolayer coated gold nanoparticles for delivery applications Adv. Drug Delivery Rev. 64, 200-16 10.1016/j.addr.2011.08.006
25. Bhattacharyya, S., Singh, R. D., Pagano, R., Robertson, J. D., Bhattacharya, R., and Mukherjee, P. (2012) Switching the targeting pathways of a therapeutic antibody by nanodesign Angew. Chem., Int. Ed. 51, 1563-7 10.1002/anie.201105432
26. Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., and Park, J. W. (2006) Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models Cancer Res. 66, 6732-40 10.1158/0008-5472.CAN-05-4199
27. Bartlett, D. W., Su, H., Hildebrandt, I. J., Weber, W. A., and Davis, M. E. (2007) Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging Proc. Natl. Acad. Sci. U. S. A. 104, 15549-54 10.1073/pnas.0707461104
28. Maina, T., Nock, B., and Mather, S. (2006) Targeting prostate cancer with radiolabelled bombesins Cancer Imaging 6, 153-7 10.1102/1470-7330.2006.0025
29. Abd-Elgaliel, W. R., Gallazzi, F., Garrison, J. C., Rold, T. L., Sieckman, G. L., Figueroa, S. D., Hoffman, T. J., and Lever, S. Z. (2008) Design, synthesis, and biological evaluation of an antagonist-bombesin analogue as targeting vector Bioconjugate Chem. 19, 2040-8 10.1021/bc800290c
30. Biddlecombe, G. B., Rogers, B. E., de Visser, M., Parry, J. J., de Jong, M., Erion, J. L., and Lewis, J. S. (2007) Molecular imaging of gastrin-releasing peptide receptor-positive tumors in mice using 64Cu- and 86Y-DOTA-(Pro1,Tyr4)-bombesin(1-14) Bioconjugate Chem. 18, 724-30 10.1021/bc060281l
31. Lin, K. S., Luu, A., Baidoo, K. E., Hashemzadeh-Gargari, H., Chen, M. K., Brenneman, K., Pili, R., Pomper, M., Carducci, M. A., and Wagner, H. N., Jr. (2005) A new high affinity technetium-99m-bombesin analogue with low abdominal accumulation Bioconjugate Chem. 16, 43-50 10.1021/bc049820h
32. Banerjee, S. R. and Pomper, M. G. (2013) Clinical applications of Gallium-68 Appl. Radiat. Isot. 76, 2-13 10.1016/j.apradiso.2013.01.039
33. Suresh, D., Zambre, A., Chanda, N., Hoffman, T. J., Smith, C. J., Robertson, J. D., and Kannan, R. (2014) Bombesin peptide conjugated gold nanocages internalize via clathrin mediated endocytosis Bioconjugate Chem. 25, 1565-79 10.1021/bc500295s
34. Shirmardi, S. P., Gandomkar, M., Maragheh, M. G., and Shamsaei, M. (2011) Preclinical evaluation of a new bombesin analog for imaging of gastrin-releasing peptide receptors Cancer Biother.Radiopharm. 26, 309-16 10.1089/cbr.2010.0912
35. Chen, Q., Ma, Q., Chen, M., Chen, B., Wen, Q., Jia, B., Wang, F., Sun, B., and Gao, S. (2015) An exploratory study on 99mTc-RGD-BBN peptide scintimammography in the assessment of breast malignant lesions compared to 99mTc-3P4-RGD2 PLoS One 10, e0123401 10.1371/journal.pone.0123401
36. Faintuch, B. L., Teodoro, R., Duatti, A., Muramoto, E., Faintuch, S., and Smith, C. J. (2008) Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies Nucl. Med. Biol. 35, 401-11 10.1016/j.nucmedbio.2008.02.005
37. Sano, K., Okada, M., Hisada, H., Shimokawa, K., Saji, H., Maeda, M., and Mukai, T. (2013) In vivo evaluation of a radiogallium-labeled bifunctional radiopharmaceutical, Ga-DOTA-MN2, for hypoxic tumor imaging Biol. Pharm. Bull. 36, 602-8 10.1248/bpb.b12-00982
38. Hnatowich, D. J., Friedman, B., Clancy, B., and Novak, M. (1981) Labeling of preformed liposomes with Ga-67 and Tc-99m by chelation J. Nucl. Med. 22, 810-4
39. Wadas, T. J., Wong, E. H., Weisman, G. R., and Anderson, C. J. (2010) Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease Chem. Rev. 110, 2858-902 10.1021/cr900325h
40. Shanehsazzadeh, S., Oghabian, M. A., Lahooti, A., Abdollahi, M., Haeri, S. A., Amanlou, M., Daha, F. J., and Allen, B. J. (2013) Estimated background doses of [Ga-67]-DTPA-USPIO in normal Balb/c mice as a potential therapeutic agent for liver and spleen cancers Nucl. Med. Commun. 34, 915-925 10.1097/MNM.0b013e328362d2fb
41. Alric, C., Taleb, J., Le Duc, G., Mandon, C., Billotey, C., Le Meur-Herland, A., Brochard, T., Vocanson, F., Janier, M., and Perriat, P. et al. 2008, Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray computed tomography and magnetic resonance imaging J. Am. Chem. Soc. 130, 5908-5915 10.1021/ja078176p
42. Shan, L. (2010) Gold Nanoparticles Coated with Dithiolated Diethylenetriamine Pentaacetic Acid-Gadolinium Chelate, in Molecular Imaging and Contrast Agent Database (MICAD), National Center for Biotechnology Information, Bethesda, MD.
43. Zambre, A., Silva, F., Upendran, A., Afrasiabi, Z., Xin, Y., Paulo, A., and Kannan, R. (2014) Synthesis and characterization of functional multicomponent nanosized gallium chelated gold crystals Chem. Commun. (Cambridge, U. K.) 50, 3281-4 10.1039/c3cc47308b
44. Debouttiere, P. J., Roux, S., Vocanson, F., Billotey, C., Beuf, O., Favre-Reguillon, A., Lin, Y., Pellet-Rostaing, S., Lamartine, R., and Perriat, P. et al. 2006, Design of gold nanoparticles for magnetic resonance imaging Adv. Funct. Mater. 16, 2330-2339 10.1002/adfm.200600242
45. Brust, M., Walker, M., Bethell, D., Schiffrin, D. J., and Whyman, R. (1994) Synthesis of thiol-derivatized gold nanoparticles in a 2-phase liquid-liquid system J. Chem. Soc., Chem. Commun. 0, 801-802 10.1039/C39940000801
46. Albanese, A., Tang, P. S., and Chan, W. C. W. (2012) The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems Annu. Rev. Biomed. Eng. 14, 1-16 10.1146/annurev-bioeng-071811-150124
47. Lindner, S., Michler, C., Wangler, B., Bartenstein, P., Fischer, G., Schirrmacher, R., and Wangler, C. (2014) PESIN Multimerization Improves Receptor Avidities and in Vivo Tumor Targeting Properties to GRPR-Overexpressing Tumors Bioconjugate Chem. 25, 489-500 10.1021/bc4004662
48. Nam, H. Y., Kwon, S. M., Chung, H., Lee, S. Y., Kwon, S. H., Jeon, H., Kim, Y., Park, J. H., Kim, J., and Her, S. et al. 2009, Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles J. Controlled Release 135, 259-267 10.1016/j.jconrel.2009.01.018
49. Rejman, J., Oberle, V., Zuhorn, I. S., and Hoekstra, D. (2004) Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis Biochem. J. 377, 159-69 10.1042/bj20031253
50. Oh, N. and Park, J. H. (2014) Endocytosis and exocytosis of nanoparticles in mammalian cells Int. J. Nanomed. 9 (Suppl 1) 51-63 10.2147/IJN.S26592
51. Kannan, R., Rahing, V., Cutler, C., Pandrapragada, R., Katti, K. K., Kattumuri, V., Robertson, J. D., Casteel, S. J., Jurisson, S., and Smith, C. et al. 2006, Nanocompatible chemistry toward fabrication of target-specific gold nanoparticles J. Am. Chem. Soc. 128, 11342-3 10.1021/ja063280c
52. Pombo Garcia, K., Zarschler, K., Barbaro, L., Barreto, J. A., O'Malley, W., Spiccia, L., Stephan, H., and Graham, B. (2014) Zwitterionic-coated "stealth" nanoparticles for biomedical applications: recent advances in countering biomolecular corona formation and uptake by the mononuclear phagocyte system Small 10, 2516-29 10.1002/smll.201303540
53. Zhao, Y., Sultan, D., Detering, L., Cho, S., Sun, G., Pierce, R., Wooley, K. L., and Liu, Y. (2014) Copper-64-alloyed gold nanoparticles for cancer imaging: improved radiolabel stability and diagnostic accuracy Angew. Chem., Int. Ed. 53, 156-9 10.1002/anie.201308494
54. Varasteh, Z., Velikyan, I., Lindeberg, G., Sorensen, J., Larhed, M., Sandstrom, M., Selvaraju, R. K., Malmberg, J., Tolmachev, V., and Orlova, A. (2013) Synthesis and characterization of a high-affinity NOTA-conjugated bombesin antagonist for GRPR-targeted tumor imaging Bioconjugate Chem. 24, 1144-53 10.1021/bc300659k
55. Schuhmacher, J., Zhang, H., Doll, J., Macke, H. R., Matys, R., Hauser, H., Henze, M., Haberkorn, U., and Eisenhut, M. (2005) GRP receptor-targeted PET of a rat pancreas carcinoma xenograft in nude mice with a 68Ga-labeled bombesin(6-14) analog J. Nucl. Med. 46, 691-9
56. Dijkgraaf, I., Franssen, G. M., McBride, W. J., D'Souza, C. A., Laverman, P., Smith, C. J., Goldenberg, D. M., Oyen, W. J., and Boerman, O. C. (2012) PET of tumors expressing gastrin-releasing peptide receptor with an 18F-labeled bombesin analog J. Nucl. Med. 53, 947-52 10.2967/jnumed.111.100891
57. Kannan, R., Pillarsetty, N., Gali, H., Hoffman, T. J., Barnes, C. L., Jurisson, S. S., Smith, C. J., and Volkert, W. A. (2011) Design and synthesis of a bombesin peptide-conjugated tripodal phosphino dithioether ligand topology for the stabilization of the fac-[M(CO)3]+ core (M = (99 m)Tc or Re) Inorg. Chem. 50, 6210-9 10.1021/ic200491z
58. Sasidharan, A., Riviere, J. E., and Monteiro-Riviere, N. A. (2015) Gold and silver nanoparticle interactions with human proteins: impact and implications in biocorona formation J. Mater. Chem. B 3, 2075-2082 10.1039/C4TB01926A
59. Berret, J. F. (2007) Stoichiometry of electrostatic complexes determined by light scattering Macromolecules 40, 4260-4266 10.1021/ma062887a
60. Peng, Q., Zhang, S., Yang, Q., Zhang, T., Wei, X. Q., Jiang, L., Zhang, C. L., Chen, Q. M., Zhang, Z. R., and Lin, Y. F. (2013) Preformed albumin corona, a protective coating for nanoparticles based drug delivery system Biomaterials 34, 8521-30 10.1016/j.biomaterials.2013.07.102
61. Salvati, A., Pitek, A. S., Monopoli, M. P., Prapainop, K., Bombelli, F. B., Hristov, D. R., Kelly, P. M., Aberg, C., Mahon, E., and Dawson, K. A. (2013) Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface Nat. Nanotechnol. 8, 137-143 10.1038/nnano.2012.237
62. Gaspar, R. (2013) Nanoparticles: Pushed off target with proteins Nat. Nanotechnol. 8, 79-80 10.1038/nnano.2013.11
63. Chen, F., Hong, H., Shi, S., Goel, S., Valdovinos, H. F., Hernandez, R., Theuer, C. P., Barnhart, T. E., and Cai, W. (2014) Engineering of hollow mesoporous silica nanoparticles for remarkably enhanced tumor active targeting efficacy Sci. Rep. 4, 5080 10.1038/srep05080